Elite Pharmaceuticals
Specialty pharmaceutical company developing abuse deterrent opioids and niche generics to curb misuse and abuse. Learn more
Launch date
Employees
Market cap
AUD664m
Enterprise valuation
AUD669m (Public information from Sep 2024)
Share price
$0.39 ELTP
Northvale New Jersey (HQ)
Authorizing premium user...